Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Cerenovus, Inc. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

168 daysmedian FDA review time
258 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K251828CEREGLIDE 71 Catheter System; Cerenovus Aspiration Tubing SeCerenovus, Inc.2025-08-22700
K241221CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 IntermediatCerenovus, Inc.2024-10-161680
K241244CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 IntermediatCerenovus, Inc.2024-10-161670
K233982CEREGLIDE 92 Catheter SystemCerenovus, Inc.2024-05-091430
K233988Cerenovus Large Bore Catheter; Cerenovus Aspiration Tubing SCerenovus, Inc.2024-01-17300
K230726CEREGLIDE 92 Intermediate CatheterCerenovus, Inc.2023-11-292580
K221934CEREGLIDE 71 Intermediate Catheter; Cerenovus Aspiration TubCerenovus, Inc.2023-03-092510
K221930CEREGLIDE 71 Intermediate CatheterCerenovus, Inc.2023-03-092510

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda